InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Fishman Corey N., 首席执行官. Director active across 1 company, notably Iterum Therapeutics plc. Aggregated, 4 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €15k. Activity tracked since 11 March 2023. The latest transaction was filed on 20 November 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Corey N. Fishman is the Chief Executive Officer at Iterum Therapeutics plc. He oversees the company's operations and is responsible for implementing its business strategy. With a strong background in the biopharmaceutical sector, Corey plays a key role in Iterum's innovation and growth while ensuring the company meets its financial objectives.